Common Contracts
8 similar Exchange Agreement contracts by Origin Life Sciences, Inc.
EXCHANGE AGREEMENTExchange Agreement • February 2nd, 2024 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of February [ ], 2024, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Victor Micati, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
EXCHANGE AGREEMENTExchange Agreement • February 2nd, 2024 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of February [ ], 2024, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Barry Christopher Vines, Sr., as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
EXCHANGE AGREEMENTExchange Agreement • February 2nd, 2024 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of February [ ], 2024, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Jerome Boda Korten, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
EXCHANGE AGREEMENTExchange Agreement • February 2nd, 2024 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of February [ ], 2024, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Anthony Brampton, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
FORM OF EXCHANGE AGREEMENTExchange Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of June [ ], 2023, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and David Dantzker, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
FORM OF EXCHANGE AGREEMENTExchange Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of June [ ], 2023, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Michael Preston, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
FORM OF EXCHANGE AGREEMENTExchange Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of June [ ], 2023, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and Alexander Dolgopolsky, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
FORM OF EXCHANGE AGREEMENTExchange Agreement • June 29th, 2023 • Origin Life Sciences, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Exchange Agreement (this “Agreement”), dated as of June [ ], 2023, is made by and between Origin Life Sciences, Inc., a Delaware corporation (the “Company”), and John Fernandes, as the holder of the Debt (as defined below) (the “Holder” and, together with the Company, the “Parties” and each individually a “Party”).
